Vaxxas

0 followers

‌

Needle-free vaccination and vaccine delivery solutions that safely and cost effectively amplify vaccine efficacy using Nanopatch technology developed by Vaxxas.

Industries

Biotechnology, Health Care

Headquarters

Sydney, Australia

Employees

51-200

Links

Org chart

David Hoey

CEO

David Hoey

Collapse

Tom Lake

Senior Vice President

Angus Forster

Chief Technology Officer

Michael Junger

Director - Industry And Government Relations

Charlotte Sweeney

Head of Formulation & Analytical

Damien Colbert

Head Of People And Performance

Deborah Pascoe, PhD

Head Of Early Stage And RNA Programs

Doug Cubbin

Chief Financial Officer

Paul Fahey

Head of Formulation & Analytical

Sarika Namjoshi, PhD

Head of Formulation and Analytical

Scott Fry

Chief Operating Officer

Dan Devine

Chief Business Officer/General Counsel/EVP

Kevin Black, CPA, MBA

Head, Special Projects

Michael Larcom

Senior Vice President of Quality

Teams

+11

Research and Development

14 members

Medical Device Engineering

12 members

Management Team

7 members

Engineering Team

5 members

Project Management

5 members

Leadership Team

3 members

Similar companies

Kura Oncology

18 followers

REVOLUTION Medicines

5 followers

Immunovant

5 followers

Fusion Pharmaceuticals

4 followers

Merck

217 followers

Focus Staff

16 followers

Relay Therapeutics

1 follower

Volastra

1 follower

Poppi

10 followers

Cochlear

2 followers

Grow Therapy

2 followers

Explore companies